A comment on "a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia" by Zhou et al.

Authors :: Demirci U
Umit EG
Demir AM
Source :: American journal of hematology [Am J Hematol] 2020 Apr; Vol. 95 (4), pp. E103-E104. Date of Electronic Publication: 2020 Feb 03.
Publication Year :: 2020

Subjects :: Adult
Antimetabolites, Antineoplastic therapeutic use
Azacitidine therapeutic use
Decitabine therapeutic use
Humans
Prospective Studies
Purpura, Thrombocytopenic, Idiopathic drug therapy

Full Text Access

Tools